Amundi reduced its stake in Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 6.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 2,018,188 shares of the basic materials company's stock after selling 138,705 shares during the quarter. Amundi owned approximately 0.46% of Cameco worth $82,564,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CCJ. Manchester Capital Management LLC lifted its holdings in Cameco by 100.0% in the 1st quarter. Manchester Capital Management LLC now owns 600 shares of the basic materials company's stock worth $25,000 after purchasing an additional 300 shares during the last quarter. Dagco Inc. acquired a new stake in Cameco in the 1st quarter worth approximately $28,000. SVB Wealth LLC acquired a new stake in Cameco in the 1st quarter worth approximately $29,000. Copia Wealth Management acquired a new stake in Cameco in the 4th quarter worth approximately $39,000. Finally, Ameriflex Group Inc. acquired a new stake in Cameco in the 4th quarter worth approximately $40,000. 70.21% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. National Bankshares reiterated an "outperform" rating on shares of Cameco in a report on Friday, August 22nd. Sanford C. Bernstein set a $70.00 price target on Cameco and gave the stock an "outperform" rating in a report on Tuesday, June 10th. Wall Street Zen upgraded Cameco from a "hold" rating to a "buy" rating in a report on Sunday. UBS Group reiterated a "buy" rating on shares of Cameco in a report on Tuesday, June 10th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Cameco in a report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating and twelve have given a Buy rating to the company. According to data from MarketBeat, Cameco has an average rating of "Buy" and a consensus target price of $83.32.
Get Our Latest Analysis on CCJ
Cameco Stock Performance
Shares of NYSE CCJ opened at $75.85 on Friday. The business has a fifty day simple moving average of $75.64 and a 200 day simple moving average of $58.82. The company has a current ratio of 2.96, a quick ratio of 2.00 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $33.02 billion, a price-to-earnings ratio of 87.18 and a beta of 1.04. Cameco Corporation has a one year low of $35.00 and a one year high of $83.02.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last issued its earnings results on Thursday, July 31st. The basic materials company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.22. The business had revenue of $467.72 million during the quarter, compared to analyst estimates of $819.79 million. Cameco had a return on equity of 8.21% and a net margin of 14.97%.Cameco's revenue was up 46.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.14 earnings per share. Cameco has set its FY 2025 guidance at EPS. Sell-side analysts expect that Cameco Corporation will post 1.27 EPS for the current year.
About Cameco
(
Free Report)
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.